Prosecution Insights
Last updated: November 11, 2026

Dow Argosciences LLC

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Dow Argosciences LLC maintains a focused presence in the Biotechnology & Pharmaceuticals sector. The portfolio currently includes 1 pending office action located in 1 distinct art unit. This concentration indicates a specific area of technical interest for the company's current filings.

BROWE, DAVID is the 1 distinct examiner for this portfolio and holds the 1 busiest examiner pending action. Since all prosecution activity is directed through a single examiner, the entity experiences a centralized review process. This structure allows for a very direct line of communication with the patent office.

Practitioners should recognize that the outcome of the single pending action is the primary measure of the portfolio's current health. The lack of examiner diversity means that the entity must successfully navigate the specific requirements of one individual. A focused and well-supported response is necessary to address the examiner's concerns effectively.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
0
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
BROWE, DAVID 1 26.8% +27.8%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
16959927 HIGH-LOAD HALOXYFOP ESTER COMPOSITIONS BROWE, DAVID —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
16959927 HIGH-LOAD HALOXYFOP ESTER COMPOSITIONS BROWE, DAVID —

Top Art Units

Art UnitApps
1617 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
16959927 HIGH-LOAD HALOXYFOP ESTER COMPOSITIONS BROWE, DAVID 1617 §103 Final Rejection — Pending Jul 02, 2020

Managing Dow Argosciences LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Dow Argosciences LLC have?

Dow Argosciences LLC has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Dow Argosciences LLC applications?

David Browe has the most, with 1 of Dow Argosciences LLC's pending office actions.

What technology area are Dow Argosciences LLC's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month